双极性障碍中的RNA生物标志物和对情绪稳定剂的反应
Claudia Pisanu1, Alessio Squassina1,2
1Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, Italy.
International journal of molecular sciences
|June 28, 2023
概括
双极性障碍 (BD) 缺乏可靠的生物标志物来诊断或治疗反应. RNA转录,包括信使RNA和非编码RNA,显示出作为BD及其治疗结果的外围标记物的潜力.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 双极性障碍 (BD) 是导致残疾的重要原因,特别是在年轻人中.
- 目前对BD的诊断和治疗反应评估缺乏可靠的生物标志物.
- RNA转录提供了超越全基因组关联研究的潜在互补见解.
研究的目的:
- 审查关于RNA转录作为双极性障碍 (BD) 外围标记物的有用性的人类研究.
- 评估RNA生物标志物,以预测对等情绪稳定剂的临床反应.
- 探索编码和非编码RNA在BD病原和治疗中的作用.
主要方法:
- 对研究信使RNA,microRNA,圆形RNA和长非编码RNA的人类研究的叙述性综述.
- 对研究的分析,重点关注BD诊断和治疗反应的外围标志物.
- 包括使用有针对性和无假设设计的研究,包括集成的RNA数据.
- 考虑来自诱导多能干细胞衍生的神经元和大脑器官的发现.
主要成果:
- 在研究设计,细胞类型和检查RNA标记物的生物流体中存在异质性.
- 越来越多的研究采用无假设方法,并整合编码和非编码RNA数据.
- 来自iPSC衍生神经元和大脑器官等细胞模型的初步发现显示出有希望.
- 使者RNA和各种非编码RNA正在作为BD.的潜在外围生物标志物进行研究.
结论:
- 包括编码和非编码类型在内的RNA转录代表了在双相情感障碍中识别生物标志物的有前途领域.
- 进一步研究整合多种RNA类型和先进的细胞模型对于开发可靠的诊断和预后工具至关重要.
- 外围RNA标记物可以通过告知诊断和治疗选择,显著改善双相情感障碍的临床管理.
相关概念视频
Bipolar Disorder
109
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
109
Mania and Antimanic Drugs: Overview
253
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
253
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
127
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
127
Antidepressant Drugs: MAOIs and Other Agents
279
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
279
Human Genetics
625
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
625
Psychosis: Goals of Pharmacotherapy
171
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
171


